Symmetry Medical, Inc. (SMA) Misses Q3 EPS by 8c, Cuts FY11 Guidance
Tweet
Share
E-mailGet Alerts SMA Hot Sheet
Price: $34.15 -0.23%
Financial Fact:
Derivative valuation gain: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Derivative valuation gain: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Symmetry Medical, Inc. (NYSE: SMA) reported Q3 EPS of $0.04, $0.08 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $84 million versus the consensus estimate of $86.42 million.
Symmetry Medical, Inc. sees FY2011 EPS of $0.31-$0.35, versus prior guidance of $0.43-$0.57 and the consensus of $0.52. Symmetry Medical, Inc. sees FY2011 revenue of $350-$360 million, versus prior guidance of $354-$370 million and the consensus of $365.13 million.
Symmetry Medical, Inc. sees FY2011 EPS of $0.31-$0.35, versus prior guidance of $0.43-$0.57 and the consensus of $0.52. Symmetry Medical, Inc. sees FY2011 revenue of $350-$360 million, versus prior guidance of $354-$370 million and the consensus of $365.13 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
